Work

Preclinical development of Meta-[211At]astatobenzylguanidine ([211At]MABG) as an alpha particle emitting systemic targeted radiotherapeutic for neuroblastoma (NB).

Year: 2015

Type: article

Source: Journal of Nuclear Medicine

Authors: Vandana Batra, Mehran Makvandi, Pietro Ranieri, Matthew Tsang, Catherine Hou, Yimei Li, Ganesan Vaidyanathan, John M. Maris, Daniel A. Pryma

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, Duke Medical Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2282036774

FWCI:

Cites:

Cited by:

Related to: 10